CG 428

CG 428

Indicaton

Severe Hair Loss (chemotherapy-induced, etc)

Therapeutic indications

Dermatology

Type of product

Other

Table

Phase

Phase III completed
Partnering status

Partnered
Partner

Abbott
Available in

Japan, Thailand

You may also be interested in

AUP-16 (AUP1602-C)

AUP-16 multi-targeting therapy for chronic wounds (Diabetic Foot Ulcers...) shows 50% improvement vs placebo in Phase-2 RCT

Phase II completed

Bimiralisib, topical [PQR309] (panPI3K/mTOR)

Non-melanoma skin cancers and rare genetic skin manifestations.

Discovery

A2AR positive allosteric modulator

Multiple, see therapeutic areas. GI indications also relevant.

Discovery